A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE
Latest Information Update: 25 Nov 2020
At a glance
- Drugs Amisulpride (Primary) ; Olanzapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms COMBINE
- 14 Jan 2019 Status changed from active, no longer recruiting to completed.
- 08 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 23 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Apr 2020.